Quick Answer
HUTCHMED (China) Ltd reported Diluted EPS of $0.52 per share for fiscal year 2025.
HUTCHMED (China) Ltd Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.52 | +1200.0% |
| 2024 | $0.04 | -66.7% |
| 2023 | $0.12 | +127.9% |
| 2022 | -$0.43 | -72.0% |
| 2021 | -$0.25 | -38.9% |
| 2020 | -$0.18 | -12.5% |
| 2019 | -$0.16 | +85.8% |
| 2018 | -$1.13 | -162.8% |
| 2017 | -$0.43 | -315.0% |
| 2016 | $0.20 | +131.2% |
| 2015 | -$0.64 | — |
- HUTCHMED (China) Ltd showed an increase of +1200.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2015–2025 period, HUTCHMED (China) Ltd’s diluted eps has grown by 181.3% (from $0.64 per share (loss) to $0.52 per share).
- The most recent figure is from HUTCHMED (China) Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: